Currently also: Chief Informatics and Technology Officer (CITO) at Pangea Botanica, London/UK and Berlin/Germany
Previous positions:
Director Digital Chemistry at NUVISAN Berlin
Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
- Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics
Publications
Simultaneous Prediction of four ATP‐binding Cassette Transporters’ Substrates Using Multi‐label QSAR
Mol Inform
(2016)
35
514
(doi: 10.1002/minf.201600036)
Analysis of Differential Efficacy and Affinity of GABAA (α1/α2) Selective Modulators.
Molecular Pharmaceutics
(2016)
13
4001
Data-Driven Derivation of an "informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening
Journal of chemical information and modeling
(2016)
56
1622
(doi: 10.1021/acs.jcim.6b00244)
Understanding Cytotoxicity and Cytostaticity in a High-Throughput Screening Collection
ACS Chemical Biology
(2016)
11
3007
(doi: 10.1021/acschembio.6b00538)
Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes
Journal of ethnopharmacology
(2016)
197
61
(doi: 10.1016/j.jep.2016.07.058)
Synthesis and in vitro evaluation of hydrazinyl phthalazines against malaria parasite, Plasmodium falciparum
Bioorg Med Chem Lett
(2016)
26
3300
(doi: 10.1016/j.bmcl.2016.05.049)
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015.
Journal of cheminformatics
(2016)
8
18
(doi: 10.1186/s13321-016-0119-5)
Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway
PloS one
(2016)
11
e0153155
(doi: 10.1371/journal.pone.0153155)
Improving the prediction of organism-level toxicity through integration of chemical, protein target and cytotoxicity qHTS data†
Toxicology research
(2016)
5
883
(doi: 10.1039/c5tx00406c)
Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
ACS chemical biology
(2016)
11
1255
(doi: 10.1021/acschembio.6b00029)
- ‹ previous
- Page 20